Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Regeneron to acquire 23andMe’s core assets for $256m amid court-supervised bankruptcy sale
Regeneron to acquire 23andMe’s core assets for $256M in a court-supervised deal. Learn how this biotech merger impacts DNA data privacy, investor sentiment, and the ... Read More
Salesforce and Takeda partner to transform pharma engagement with AI-driven Life Sciences Cloud platform
Discover how Salesforce and Takeda are redefining pharma engagement using AI-powered Life Sciences Cloud. Learn how data, AI, and patient outcomes align. Read More
Halozyme Therapeutics stock rises 6.27% after beating Q1 expectations, raising 2025 outlook
Halozyme Therapeutics stock rose as Q1 earnings beat expectations and 2025 guidance improved. See how ENHANZE® drives royalty growth and future prospects. Read More
How do Vutrisiran’s HELIOS-B results compare with historical standards in ATTR-CM treatment?
Alnylam’s vutrisiran reduces cardiovascular mortality and urgent heart failure visits in ATTR-CM, reinforcing AMVUTTRA’s first-line potential. Read key data now. Read More
Be Biopharma reports positive preclinical data for BE-102 in hypophosphatasia
Be Biopharma shares preclinical results for BE-102, a B cell medicine in development for treating hypophosphatasia. Read about its novel approach. Read More
Apellis Pharmaceuticals gains 6.66% as investors bet on Q2 trial update and long-term pipeline potential
Apellis Pharmaceuticals stock jumped 6.66% as investors bet on key trial updates and undervalued biotech potential. Will FDA decisions drive more upside? Read More
CRISPR Therapeutics stock jumps 6.77% as institutional rebalancing favors gene-editing names
CRISPR Therapeutics stock rose 6.77% as funds rotated back into gene-editing names. Find out what’s driving the rebound and what lies ahead for CRSP. Read More
Zai Lab stock rallies on regulatory optimism in China’s oncology sector
Zai Lab stock jumps 7.6% on China FDA review optimism for its oncology drugs, as cross-border biotech sentiment improves. Read the full investor analysis. Read More
Be Biopharma unveils promising preclinical data for BE-102 B cell therapy targeting hypophosphatasia
In a notable advancement for genetic bone disorder therapies, Be Biopharma Inc. has presented new preclinical data for BE-102, its lead B Cell Medicine (BCM) ... Read More
Tonix Pharmaceuticals stock up over 20%: Can TNX-102 SL and TNX-1700 fuel a turnaround in 2025?
Tonix Pharmaceuticals surged 21% despite deep losses, as retail traders bet on TNX-102 SL’s FDA nod and cancer pipeline momentum. Read the full story. Read More